Explore
Validate
Learn
Immunohistochemistry
Other assayAntibody data
- Antibody Data
- Antigen structure
- References [14]
- Comments [0]
- Validations
- Other assay [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- MA1-35420 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- HLA-DR Monoclonal Antibody (LN-3)
- Antibody type
- Monoclonal
- Antigen
- Other
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- LN-3
- Vial size
- 1 mL
- Concentration
- 250 µg/mL
- Storage
- 4° C
Submitted references T Cells Actively Infiltrate the White Matter of the Aging Monkey Brain in Relation to Increased Microglial Reactivity and Cognitive Decline.
Frequent amplification of HDAC genes and efficacy of HDAC inhibitor chidamide and PD-1 blockade combination in soft tissue sarcoma.
Effects of B Cell Depletion on Early Mycobacterium tuberculosis Infection in Cynomolgus Macaques.
Particular activation phenotype of T cells expressing HLA-DR but not CD38 in GALT from HIV-controllers is associated with immune regulation and delayed progression to AIDS.
Temporal Dynamics of CD8+ T Cell Effector Responses during Primary HIV Infection.
Trained immunity in newborn infants of HBV-infected mothers.
Evidence for innate immune system activation in HIV type 1-infected elite controllers.
SUCLG2 identified as both a determinator of CSF Aβ1-42 levels and an attenuator of cognitive decline in Alzheimer's disease.
Tissue specificity of decellularized rhesus monkey kidney and lung scaffolds.
Appearance of tissue transglutaminase in astrocytes in multiple sclerosis lesions: a role in cell adhesion and migration?
Dynamics of immune granuloma formation in a Leishmania braziliensis-induced self-limiting cutaneous infection in the primate Macaca mulatta.
Endometrial atypical hyperplasia with clear cell change spreading throughout the endometrium.
Identification of new MHC-restriction elements for presentation of the p210(BCR-ABL) fusion region to human cytotoxic T lymphocytes.
Human macrophage lectin specific for galactose/N-acetylgalactosamine is a marker for cells at an intermediate stage in their differentiation from monocytes into macrophages.
Batterman KV, Cabrera PE, Moore TL, Rosene DL
Frontiers in immunology 2021;12:607691
Frontiers in immunology 2021;12:607691
Frequent amplification of HDAC genes and efficacy of HDAC inhibitor chidamide and PD-1 blockade combination in soft tissue sarcoma.
Que Y, Zhang XL, Liu ZX, Zhao JJ, Pan QZ, Wen XZ, Xiao W, Xu BS, Hong DC, Guo TH, Shen LJ, Fan WJ, Chen HY, Weng DS, Xu HR, Zhou PH, Zhang YZ, Niu XH, Zhang X
Journal for immunotherapy of cancer 2021 Feb;9(2)
Journal for immunotherapy of cancer 2021 Feb;9(2)
Effects of B Cell Depletion on Early Mycobacterium tuberculosis Infection in Cynomolgus Macaques.
Phuah J, Wong EA, Gideon HP, Maiello P, Coleman MT, Hendricks MR, Ruden R, Cirrincione LR, Chan J, Lin PL, Flynn JL
Infection and immunity 2016 May;84(5):1301-1311
Infection and immunity 2016 May;84(5):1301-1311
Particular activation phenotype of T cells expressing HLA-DR but not CD38 in GALT from HIV-controllers is associated with immune regulation and delayed progression to AIDS.
Gonzalez SM, Taborda NA, Correa LA, Castro GA, Hernandez JC, Montoya CJ, Rugeles MT
Immunologic research 2016 Jun;64(3):765-74
Immunologic research 2016 Jun;64(3):765-74
Temporal Dynamics of CD8+ T Cell Effector Responses during Primary HIV Infection.
Demers KR, Makedonas G, Buggert M, Eller MA, Ratcliffe SJ, Goonetilleke N, Li CK, Eller LA, Rono K, Maganga L, Nitayaphan S, Kibuuka H, Routy JP, Slifka MK, Haynes BF, McMichael AJ, Bernard NF, Robb ML, Betts MR
PLoS pathogens 2016 Aug;12(8):e1005805
PLoS pathogens 2016 Aug;12(8):e1005805
Trained immunity in newborn infants of HBV-infected mothers.
Hong M, Sandalova E, Low D, Gehring AJ, Fieni S, Amadei B, Urbani S, Chong YS, Guccione E, Bertoletti A
Nature communications 2015 Mar 25;6:6588
Nature communications 2015 Mar 25;6:6588
Evidence for innate immune system activation in HIV type 1-infected elite controllers.
Krishnan S, Wilson EM, Sheikh V, Rupert A, Mendoza D, Yang J, Lempicki R, Migueles SA, Sereti I
The Journal of infectious diseases 2014 Mar;209(6):931-9
The Journal of infectious diseases 2014 Mar;209(6):931-9
SUCLG2 identified as both a determinator of CSF Aβ1-42 levels and an attenuator of cognitive decline in Alzheimer's disease.
Ramirez A, van der Flier WM, Herold C, Ramonet D, Heilmann S, Lewczuk P, Popp J, Lacour A, Drichel D, Louwersheimer E, Kummer MP, Cruchaga C, Hoffmann P, Teunissen C, Holstege H, Kornhuber J, Peters O, Naj AC, Chouraki V, Bellenguez C, Gerrish A, International Genomics of Alzheimer's Project (IGAP), Alzheimer's Disease Neuroimaging Initiative (ADNI), Heun R, Frölich L, Hüll M, Buscemi L, Herms S, Kölsch H, Scheltens P, Breteler MM, Rüther E, Wiltfang J, Goate A, Jessen F, Maier W, Heneka MT, Becker T, Nöthen MM
Human molecular genetics 2014 Dec 15;23(24):6644-58
Human molecular genetics 2014 Dec 15;23(24):6644-58
Tissue specificity of decellularized rhesus monkey kidney and lung scaffolds.
Nakayama KH, Lee CC, Batchelder CA, Tarantal AF
PloS one 2013;8(5):e64134
PloS one 2013;8(5):e64134
Appearance of tissue transglutaminase in astrocytes in multiple sclerosis lesions: a role in cell adhesion and migration?
van Strien ME, Drukarch B, Bol JG, van der Valk P, van Horssen J, Gerritsen WH, Breve JJ, van Dam AM
Brain pathology (Zurich, Switzerland) 2011 Jan;21(1):44-54
Brain pathology (Zurich, Switzerland) 2011 Jan;21(1):44-54
Dynamics of immune granuloma formation in a Leishmania braziliensis-induced self-limiting cutaneous infection in the primate Macaca mulatta.
Souza-Lemos C, de-Campos SN, Teva A, Côrte-Real S, Fonseca EC, Porrozzi R, Grimaldi G Jr
The Journal of pathology 2008 Nov;216(3):375-86
The Journal of pathology 2008 Nov;216(3):375-86
Endometrial atypical hyperplasia with clear cell change spreading throughout the endometrium.
Nakashima N, Nagasaka T, Murakami S, Fukatsu T, Satake T
Annals of diagnostic pathology 2003 Dec;7(6):381-6
Annals of diagnostic pathology 2003 Dec;7(6):381-6
Identification of new MHC-restriction elements for presentation of the p210(BCR-ABL) fusion region to human cytotoxic T lymphocytes.
Sun JY, Senitzer D, Forman SJ, Chatterjee S, Wong KK Jr
Cancer immunology, immunotherapy : CII 2003 Dec;52(12):761-70
Cancer immunology, immunotherapy : CII 2003 Dec;52(12):761-70
Human macrophage lectin specific for galactose/N-acetylgalactosamine is a marker for cells at an intermediate stage in their differentiation from monocytes into macrophages.
Higashi N, Morikawa A, Fujioka K, Fujita Y, Sano Y, Miyata-Takeuchi M, Suzuki N, Irimura T
International immunology 2002 Jun;14(6):545-54
International immunology 2002 Jun;14(6):545-54
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- NULL
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Fig 2 Memory distributions, activation, and proportion of cytotoxic peripheral CD8 + T cells for healthy donors and following HIV infection. ( A ) Representative flow cytometric plots of CCR7 versus CD45RO from a pre- (day -159) and acute (day 28) infection time point for one donor. ( B ) Proportion of circulating total memory CD8 + T cells for all healthy donors (HD; n = 41), acute HIV time points (23-100 d; n = 27), and chronic HIV time points (>365 d; n = 23). ( C ) Peak viral load plotted against total memory CD8 + T cells at the earliest available time point post-infection (23-41 d) for each RV217 donor. Spearman's rank correlation test was used to determine significance. ( D ) Memory subsets as determined by CCR7 and CD45RO staining for all healthy donors (circles), acute HIV time points (squares), and chronic HIV time points (triangles). ( E ) Proportion of memory CD8 + T cells that express HLA-DR over time from infection for four RV217 subjects. Pre-infection time points were set as day 0 for analysis. ( F ) Representative flow cytometric plots of perforin and HLA-DR expression by memory CD8 + T cells from a pre- (day -173), acute (day 31), and chronic (day 420) infection time point for one donor. SS Day 420 sample was acquired and analyzed at a later date than earlier samples resulting in a different gating scheme. For consistency, gates were set using naive (CCR7 + CD45RO - ) CD8 + T cells, which generally do not express perforin or HLA-DR. ( G ) Proportion of
